India's obesity drug market is experiencing rapid growth, driven by rising lifestyle diseases and the launch of blockbuster therapies. The impending entry of low-cost generics is set to further accelerate this expansion, making treatments more accessible to a wider population beyond urban elites.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4v5Ooz6
via IFTTT
No comments:
Post a Comment